Literature DB >> 24888917

Clinical analysis of 65 cases of hyperemesis gravidarum with gestational transient thyrotoxicosis.

Shuiya Sun1, Xia Qiu, Jiaqiang Zhou.   

Abstract

AIM: We investigated thyroid function and the impact of gestational transient thyrotoxicosis (GTT) on pregnancy outcome in patients with hyperemesis gravidarum (HG; n = 143) who were hospitalized for rehydration.
METHODS: Serum thyroid-stimulating hormone (TSH), free T3 (FT3), free T4 (FT4), thyroid globulin antibody (TgAb), thyroid peroxidase antibody (TPOAb) and hCG were measured after admission.
RESULTS: The total prevalence of thyrotoxicosis in HG was 48.3%; GTT was the main form (45.5%). The total incidence of GTT increased significantly if serum hCG was more than 80,000 IU/L, subclinical GTT if serum hCG was 80,000-140,000 IU/L and clinical GTT if serum hCG was more than 180,000 IU/L. GTT did not require antithyroid therapy. The course of TSH, FT3 and FT4 were followed in 34 cases of GTT; thyroid function normalized by the second trimester. Of 65 patients with GTT, two underwent abortions due to unplanned pregnancies, two delivered prematurely and two infants had macrosomia. There were no other complications. All newborns (n = 63) of mothers with GTT had normal TSH levels.
CONCLUSION: GTT is common in HG. The severity of GTT is related to serum hCG levels. In patients with HG and GTT, thyroid function normalized by the second trimester without antithyroid treatment. GTT did not affect pregnancy outcomes.
© 2014 The Authors. Journal of Obstetrics and Gynaecology Research © 2014 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  free T3; free T4; gestational transient thyrotoxicosis; hCG; hyperemesis gravidarum; thyroid-stimulating hormone

Mesh:

Substances:

Year:  2014        PMID: 24888917     DOI: 10.1111/jog.12372

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  7 in total

Review 1.  Advances in the differential diagnosis of transient hyperthyroidism in pregnancy and Graves' disease.

Authors:  Nian Guo; Meng Xue; Zhen Liang
Journal:  Arch Gynecol Obstet       Date:  2022-09-16       Impact factor: 2.493

2.  Thyroid Storm Caused by Hyperemesis Gravidarum.

Authors:  Chelsea F Zimmerman; Alexandra B Ilstad-Minnihan; Brittany S Bruggeman; Bradley J Bruggeman; Kristin J Dayton; Nancy Joseph; Daniel I Moas; Henry J Rohrs
Journal:  AACE Clin Case Rep       Date:  2022-01-03

Review 3.  Nausea and vomiting of pregnancy - What's new?

Authors:  Martha Bustos; Raman Venkataramanan; Steve Caritis
Journal:  Auton Neurosci       Date:  2016-05-13       Impact factor: 3.145

4.  Ambulatory versus inpatient management of severe nausea and vomiting of pregnancy: a randomised control trial with patient preference arm.

Authors:  Nicola Mitchell-Jones; Jessica Alice Farren; Aurelio Tobias; Tom Bourne; Cecilia Bottomley
Journal:  BMJ Open       Date:  2017-12-05       Impact factor: 2.692

Review 5.  Management of Endocrinopathies in Pregnancy: A Review of Current Evidence.

Authors:  Daniela Calina; Anca Oana Docea; Kirill Sergeyevich Golokhvast; Stavros Sifakis; Aristides Tsatsakis; Antonis Makrigiannakis
Journal:  Int J Environ Res Public Health       Date:  2019-03-04       Impact factor: 3.390

6.  Life-threatening complications of hyperemesis gravidarum.

Authors:  Stefan L Popa; Maria Barsan; Alexandra Caziuc; Cristina Pop; Lucian Muresan; Luminita Celia Popa; Lacramioara Perju-Dumbrava
Journal:  Exp Ther Med       Date:  2021-04-16       Impact factor: 2.447

7.  Thyroid-stimulating hormone and free thyroxine fail to predict the severity and clinical course of hyperemesis gravidarum: A prospective cohort study.

Authors:  Kelly Nijsten; Marjette H Koot; Joris A M van der Post; Joke M J Bais; Carrie Ris-Stalpers; Christiana Naaktgeboren; Henk A Bremer; David P van der Ham; Wieteke M Heidema; Anjoke Huisjes; Gunilla Kleiverda; Simone M Kuppens; Judith O E H van Laar; Josje Langenveld; Flip van der Made; Dimitri Papatsonis; Marie-José Pelinck; Paula J Pernet; Leonie van Rheenen-Flach; Robbert J Rijnders; Hubertina C J Scheepers; Sarah E Siegelaar; Tatjana Vogelvang; Ben W Mol; Tessa J Roseboom; Iris J Grooten; Rebecca C Painter
Journal:  Acta Obstet Gynecol Scand       Date:  2021-03-12       Impact factor: 4.544

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.